Renal and cardiovascular toxicity of non-steroidal anti-inflammatory drugs

Inflammopharmacology

Volumn 8, Issue 1, 2000, Pages 1-18

  McGettigan, P ^a   Platona, A ^a   Henry, D A ^a  

^a NEWCASTLE MATER HOSPITAL   (Australia)

Author keywords

Cyclo oxygenase (COX); Epidemiology; Heart failure; Hypertension; Non steroidal anti inflammatory drugs (NSAIDs); Renal failure; Review

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ALDOSTERONE; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; CREATININE; DIURETIC AGENT; ELECTROLYTE; ENDOTHELIN 1; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENACETIN; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; RENIN; SODIUM; VASODILATOR AGENT; WATER;

ANALGESIC NEPHROPATHY; ARTICLE; CARDIOTOXICITY; CLINICAL TRIAL; GASTROINTESTINAL SYMPTOM; GLOMERULUS FILTRATION RATE; HEART FAILURE; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOALDOSTERONISM; KIDNEY FAILURE; MEAN ARTERIAL PRESSURE; NEPHROTOXICITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0033935803     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1163/15685600052062734     Document Type: Article

References (28)

1. W. Ailabouni G. Eknoyan 1996 Non-steroidal anti-inflammatory drugs and acute renal failure in the elderly. A risk benefit assessment Drugs & Aging 5 341 51 Ailabouni, W. and Eknoyan, G. (1996). Non-steroidal anti-inflammatory drugs and acute renal failure in the elderly. A risk benefit assessment, Drugs & Aging 5, 341–51.
2. Anon. Script. Issue No. 2312; p. 7. 25/2/98.
3. J. Calvo-Alen M. A. De Cos V. Rodriguez-Valverde R. Escallada J. Florez M. Arias 1994 Subclinical renal toxicity in rheumatic patients receiving longterm treatment with non-steroidal anti-inflammatory drugs J. Rheumatol. 21 1742 7 Calvo-Alen, J., De Cos, M. A., Rodriguez-Valverde, V., Escallada, R., Florez, J. and Arias, M. (1994). Subclinical renal toxicity in rheumatic patients receiving longterm treatment with non-steroidal anti-inflammatory drugs, J. Rheumatol. 21, 1742–7.
4. J. Dequeker C. Hawkey A. Kahan K. Steinbruck C. Alegre E. Baumelou B. Begaud H. Isomaki G. Littlejohn J. Mau S. Papazoglou 1998 Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis British Journal of Rheumatology 37 9 946 51 Dequeker, J., Hawkey, C., Kahan, A., Steinbruck, K., Alegre, C., Baumelou, E., Begaud, B., Isomaki, H., Littlejohn, G., Mau, J. and Papazoglou, S. (1998). Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis, British Journal of Rheumatology 37 (9), 946–51.
5. V. J. Dzau M. Packer L. S. Lilly S. L. Swartz N. K. Hollenberg G. H. Williams 1984 Prostaglandins in severe congestive heart failure. Relation to activation of the renin-angiotensin system and hyponatraemia N. Engl. J. Med. 310 347 52 Dzau, V. J., Packer, M., Lilly, L. S., Swartz, S. L., Hollenberg, N. K. and Williams, G. H. (1984). Prostaglandins in severe congestive heart failure. Relation to activation of the renin-angiotensin system and hyponatraemia, N. Engl. J. Med. 310, 347–52.
6. J. M. Evans E. McGregor A. D. McMahon M. M. McGilchrist M. C. Joens G. White D. G. McDevitt T. M. MacDonald 1995 Non-steroidal anti-inflammatory drugs and hospitalisation for acute renal failure QJM 88 8 551 7 Evans, J. M., McGregor, E., McMahon, A. D., McGilchrist, M. M., Joens, M. C., White, G., McDevitt, D. G. and MacDonald, T. M. (1995). Non-steroidal anti-inflammatory drugs and hospitalisation for acute renal failure, QJM 88 (8), 551–7.
7. H. I. Feldman J. L. Kinman J. A. Berlin S. Hennessy S. E. Kimmel J. Farrar J. L. Carson B. L. Strom 1997 Parenteral ketorolac: the risk for acute renal failure Ann. Intern. Med. 126 193 9 Feldman, H. I., Kinman, J. L., Berlin, J. A., Hennessy, S., Kimmel, S. E., Farrar, J., Carson, J. L. and Strom, B. L. (1997). Parenteral ketorolac: the risk for acute renal failure, Ann. Intern. Med. 126, 193–9.
8. D. W. Gilroy P. R. Colville-Nash D. Willis J. Chivers J. Paul-Clarke D. A. Willoughby 1999 Inducible cyclooxygenase may have anti-inflammatory properties Nature Medicine 5 6 698 701 Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clarke, J. and Willoughby, D. A. (1999). Inducible cyclooxygenase may have anti-inflammatory properties, Nature Medicine 5 (6), 698–701.
9. A. P. Gutthann L. A. Garcia Rodriguez D. S. Raiford A. D. Oliart J. R. Romeu 1996 Non-steroidal anti-inflammatory drugs and the risk of hospitalisation for acute renal failure Arch. Intern. Med. 156 2433 9 Gutthann, A. P., Garcia Rodriguez, L. A., Raiford, D. S., Oliart A. D. and Romeu, J. R. (1996). Non-steroidal anti-inflammatory drugs and the risk of hospitalisation for acute renal failure, Arch. Intern. Med. 156, 2433–9.
10. C. Hawkey A. Kahan K. Steinbruck C. Alegre E. Baumelou B. Begaud J. Dequeker H. Isomaki G. Littlejohn J. Mau S. Papazoglou 1998 Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxi-cam Large-scale International Study Safety Assessment British Journal of Rheumatology 37 9 937 45 Hawkey, C., Kahan, A., Steinbruck, K., Alegre, C., Baumelou, E., Begaud, B., Dequeker, J., Isomaki, H., Littlejohn, G., Mau, J. and Papazoglou, S. (1998). Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxi-cam Large-scale International Study Safety Assessment, British Journal of Rheumatology 37 (9), 937–45.
11. C. I. Hawkey 1999 COX-2 inhibitors Lancet 353 307 14 Hawkey, C. I. (1999). COX-2 inhibitors, Lancet 353, 307–14.
12. E. R. Heerdink H. G. Leufkens R. M. C. Herings J. P. Ottervanger B. H. C. Stricker A. Bakker 1998 NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics Arch. Intern. Med. 158 1108 12 Heerdink, E. R., Leufkens, H. G., Herings, R. M. C., Ottervanger, J. P., Stricker, B. H. C. and Bakker, A. (1998). NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics, Arch. Intern. Med. 158, 1108–12.
13. D. A. Henry P. R. McGregor A. Dobson C. L. Turner 1992 Effects of prior use of non-steroidal anti-inflammatory drugs on renal function and transfusion requirements after upper gastrointestinal haemorrhage Eur. J. Clin. Pharmacol. 43 341 5 Henry, D. A., McGregor, P. R., Dobson, A. and Turner, C. L. (1992). Effects of prior use of non-steroidal anti-inflammatory drugs on renal function and transfusion requirements after upper gastrointestinal haemorrhage, Eur. J. Clin. Pharmacol. 43, 341–5.
14. D. Henry J. Page I. Whyte R. Nanra C. Hall 1997 Consumption of non-steroidal anti-inflammatory drugs and the development of functional renal impairment in elderly subjects. Results of a case-control study Br. J. Clin. Pharmacol. 44 85 90 Henry, D., Page, J., Whyte, I., Nanra, R. and Hall, C. (1997). Consumption of non-steroidal anti-inflammatory drugs and the development of functional renal impairment in elderly subjects. Results of a case-control study, Br. J. Clin. Pharmacol. 44, 85–90.
15. A. G. Johnson T. V. Nguyen R. O. Day 1994 Do non-steroidal anti-inflammatory drugs affect blood pressure? A meta-analysis Ann. Intern. Med. 121 289 300 Johnson, A. G., Nguyen, T. V. and Day, R. O. (1994). Do non-steroidal anti-inflammatory drugs affect blood pressure? A meta-analysis, Ann. Intern. Med. 121, 289–300.
16. J. K. McLaughlin L. Lipworth W. H. Chow W. J. Blot 1998 Analgesic use and chronic renal failure: a critical review of the epidemiologic literature Kidney International 54 679 86 McLaughlin, J. K., Lipworth, L., Chow, W. H. and Blot, W. J. (1998). Analgesic use and chronic renal failure: a critical review of the epidemiologic literature, Kidney International 54, 679–86.
17. F. O. Muller M. V. Middle R. Schall J. Terblanche H. K. L. Hundt G. Groenewoud 1997 An evaluation of the interaction of meloxicam with frusemide in patients with compensated chronic cardiac failure Br. J. Clin. Pharmacol. 44 393 8 Muller, F. O., Middle, M. V., Schall, R., Terblanche, J., Hundt, H. K. L. and Groenewoud, G. (1997). An evaluation of the interaction of meloxicam with frusemide in patients with compensated chronic cardiac failure, Br. J. Clin. Pharmacol. 44, 393–8.
18. M. D. Murray D. C. Brater 1993 Renal toxicity of the non-steroidal anti-inflammatory drugs Annu. Rev. Pharmacol. Toxicol. 32 435 65 Murray, M. D. and Brater, D. C. (1993). Renal toxicity of the non-steroidal anti-inflammatory drugs, Annu. Rev. Pharmacol. Toxicol. 32, 435–65.
19. Page, J. and Henry, D. (2000). Consumption of NSAIDs and the development of congestive heart failure in elderly subjects. An under-recognised public health problem, Arch. Intern. Med. (in press).
20. A. Perez Gutthann L. A. Garcia Rodriguez D. S. Raiford A. D. Oliart J. R. Romeu 1996 Non-steroidal anti-inflammatory drugs and the risk of hospitalisation for acute renal failure Arch. Intern. Med. 156 21 2433 9 Perez Gutthann, A., Garcia Rodriguez, L. A., Raiford, D. S., Oliart, A. D. and Romeu, J. R. (1996). Non-steroidal anti-inflammatory drugs and the risk of hospitalisation for acute renal failure, Arch. Intern. Med. 156 (21), 2433–9.
21. T. P. Perneger P. K. Whelton M. J. Klag 1994 Risk of kidney failure associated with the use of acetaminophen, aspirin, and of non-steroidal anti-inflammatory drugs N.Engl.J.Med. 331 1675 9 Perneger, T. P., Whelton, P. K. and Klag, M. J. (1994). Risk of kidney failure associated with the use of acetaminophen, aspirin, and of non-steroidal anti-inflammatory drugs, N.Engl.J.Med. 331, 1675–9.
22. J. E. Pope J. J. Anderson D. T. Felson 1993 A meta-analysis of the effects of non-steroidal anti-inflammatory drugs on blood pressure Arch. Intern. Med. 153 477 84 Pope, J. E., Anderson, J. J. and Felson, D. T. (1993). A meta-analysis of the effects of non-steroidal anti-inflammatory drugs on blood pressure, Arch. Intern. Med. 153, 477–84.
23. D. P. Sandler R. Burr C. R. Weinberg 1991 Non-steroidal anti-inflammatory drugs and the risk for chronic renal disease Ann. Intern. Med. 115 165 72 Sandler, D. P., Burr, R. and Weinberg, C. R. (1991). Non-steroidal anti-inflammatory drugs and the risk for chronic renal disease, Ann. Intern. Med. 115, 165–72.
24. M. Segasothy G. L. Chin K. K. Sia A. Zulfiqar S. A. Samad 1995 Chronic nephrotoxicity of anti-inflammatory drugs used in the treatment of arthritis Br. J. Rheumatology 34 162 5 Segasothy, M., Chin, G. L., Sia, K. K., Zulfiqar, A. and Samad, S. A. (1995). Chronic nephrotoxicity of anti-inflammatory drugs used in the treatment of arthritis, Br. J. Rheumatology 34, 162–5.
25. D. O. Stichtenoth J. C. Frolich 1998 Avoidance of renal side effects of non-steroidal anti-inflammatory drugs: value of selective cyclooxygenase-2 inhibiton J. R. Vane R. M. Botting Clinical significance and potential of selective COX-2 inhibitors William Harvey Press London Stichtenoth, D. O. and Frolich, J. C. (1998). Avoidance of renal side effects of non-steroidal anti-inflammatory drugs: value of selective cyclooxygenase-2 inhibiton, in: Clinical significance and potential of selective COX-2 inhibitors, Vane, J. R. and Botting, R. M. (Ed.). William Harvey Press, London.
26. J. N. Townend J. Doran C. J. Lote M. K. Davies 1995 Peripheral haemodynamic effects of prostaglandin synthesis in congestive heart failure and interactions with captopril Br. Heart. J. 73 5 434 41 Townend, J. N., Doran, J., Lote, C. J. and Davies, M. K. (1995). Peripheral haemodynamic effects of prostaglandin synthesis in congestive heart failure and interactions with captopril, Br. Heart. J. 73 (5), 434–41.
27. J. R. Vane R. M. Botting 1998 Overview: the mechanism of action of anti-inflammatory drugs J. R. Vane R. M. Botting Clinical significance and potential of selective COX-2 inhibitors William Harvey Press London Vane, J. R. and Botting, R. M. (1998). Overview: the mechanism of action of anti-inflammatory drugs, in: Clinical significance and potential of selective COX-2 inhibitors, Vane, J. R. and Botting, R. M. (Eds). William Harvey Press, London.
28. C. M. Venturini P. Isakson P. Needleman 1998 Non-steroidal anti-inflammatory drug-induced renal failure: a brief review of the role of cyclo-oxygenase isoforms Current Opinion in Nephrology and Hypertension 7 1 79 82 Venturini, C. M., Isakson, P. and Needleman, P. (1998). Non-steroidal anti-inflammatory drug-induced renal failure: a brief review of the role of cyclo-oxygenase isoforms, Current Opinion in Nephrology and Hypertension 7 (1), 79–82.